Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2017 - 2026)

Aurinia Pharmaceuticals has reported Other Non-Current Assets for 10 years, with the latest figure at $93000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 88.7% year-over-year to $93000.0; the trailing twelve-month figure through Mar 2026 stood at $93000.0 (down 88.7% YoY), and the FY2025 full-year result was $93000.0, down 88.7% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $93000.0, roughly flat from $93000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $13.3 million in Q4 2022, with the low at $93000.0 in Q2 2025.
• Historically, Other Non-Current Assets has averaged $3.6 million across 5 years, with a median of $868000.0 in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 4346.33% — and 2023, when it sank 94.09%.
• Aurinia Pharmaceuticals' Other Non-Current Assets stood at $13.3 million in 2022, then tumbled by 88.63% to $1.5 million in 2023, then sank by 45.75% to $823000.0 in 2024, then tumbled by 88.7% to $93000.0 in 2025, then changed by 0.0% to $93000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $93000.0 (Q1 2026), $93000.0 (Q4 2025), and $93000.0 (Q3 2025), per Business Quant data.